Comparison of the effects of a low-protein diet with the effects of a converting enzyme inhibitor on the progression of renal insufficiency in hypertensive rats

Renal Failure

Volumn 18, Issue 2, 1996, Pages 173-180

  Červenka, Luděk ^a   Heller, Jiří ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Ablation nephropathy; Angiotensin converting enzyme inhibitors; Low protein diet

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN RESTRICTION; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL RATE; UREA BLOOD LEVEL;

EID: 0029996030     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609052787     Document Type: Article

References (22)

1. Hostetter TH, Meyer TW, Rennke HG, Brenner BM: Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 30:509-517, 1986.
2. Klahr S, Purkerson ML: Effects of dietary protein on renal function and on the progression of renal disease. Am J Clin. Nutr 47:146-152, 1988.
3. Dworkin LD, Bestein JA, Parker M, Tolbert E, Feiner HD: Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int 43:808-814, 1993.
4. Amann K, Irzyniec T, Mall G, Ritz E: The effect of enalapril on glomeralar lesions after subtotal nephrectomy in the rat. a stereological analysis. J Hypertens 11:969-975, 1993
5. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986.
6. Červenka L, Heller J: A comparison of the effect of feeding a low-protein diet and of pharmacological intervention on the course of ablation nephropathy in the rat. Renal Failure 17:27-35, 1995.
7. Heller J, Hellerová S, Dobešová Z, Kuneš J, Zicha J: The Prague hypertensive rat: a new model of genetic hypertension. Clin Exp Hypertension A15:807-818, 1993.
8. Heller J, Schubert G, Havlíčková J, Thurau K: The role of the kidney in the development of hypertension: a transplantation study in the Prague Hypertensive Rat. Pflugers Arch 425:208-212, 1993.
9. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985.
10. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic changes vs hypertrophy in experimental glomerular sclerosis. Kidney Int 36:654-660, 1989.
11. Miller PL, Rennke HG, Meyer TW: Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol 261:F459-F465, 1991.
12. Berk BC, Vekshtein V, Gordon HM, Tsuda T: Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13:305-314, 1989.
13. Geistefer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62:749-756, 1988.
14. Norman JT: The role of angiotensin II in renal growth. Renal Physiol Biochem 14:175-185, 1991.
15. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 243:F83-93, 1981.
16. Okuda S, Nakamura T, Yamamoto T, Ruoslahti E: Dietary protein restriction rapidly reduces transforming growth factor β-1 expression in experimental glomerulonephritis. Proc Natl Acad Sci USA 88:9765-9769, 1991.
17. Rosenberg ME, Chmielewski D, Hostetter TH: Effect of dietary protein on the rat renin and angiotensinogen gene expression. J Clin Invest 85:1144-1149, 1990.
18. Nakamura T, Miller D, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 41:1213-1221, 1992.
19. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994.
20. Border WA, Noble NA, Yamamoto T, Harper J, Yamamguchi Y, Pierschlabacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protect against scaring in experimental kidney disease. Nature 360:361-364, 1992.
21. Stouffer GA, Owens GK: Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor. Circ Res 70:820-828, 1992.
22. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor β-1 expression determines growth response to angiotensin II. J Clin Invest 90: 456-461, 1992.